一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Archives of Gynecology and Obstetrics >>article
Archives of Gynecology and Obstetrics

Archives of Gynecology and Obstetrics

IF: 2.1
Download PDF

Depot-medroxyprogesterone acetate: an update

Published:10 May 2008 DOI: 10.1007/s00404-007-0497-z PMID: 18470526
Sayed Bakry, Zaher O. Merhi, Trudy J. Scalise, Mohamad S. Mahmoud, Ahmed Fadiel, Frederick Naftolin

Abstract

Objective

Depo-Provera? is a contraceptive approved by the US Food and Drug Administration (FDA) since 1992 and used worldwide by more than 90 million women.

Aim of study

Despite the fact that progestins are endogenous hormones that are secreted by the body, its excess might lead to detrimental health effects. Whether progestins as contraceptives are friends or foes is a questionable matter. In this manuscript, we drive the attention to both usage and side effects Depo-Provera.

Results

Depot-medroxyprogesterone acetate (DMPA) is a highly effective, convenient non-daily hormonal contraceptive option that has been available worldwide for many years. The experience with DMPA provides a large body of long-term data regarding the efficacy and safety of this contraceptive method; this long-term experience has established that the use of DMPA does not increase the risk of cardiovascular events, breast cancer, other gynecologic malignancy, or postmenopausal fracture; however, patients are often more concerned about the relatively immediate effects of contraceptives such as potential changes in menstrual cycle, body weight, and mood disturbances.

Conclusion

Concerns about such issues may lead to reluctance to initiate therapy or premature discontinuation. Counseling and understanding of women’s concerns and experiences using Depo-Provera is important and could help health care providers redesign counseling strategies to improve contraceptive continuation and improve patient adherence.

Substances (2)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Medroxyprogesterone Acetate 71-58-9 C24H34O4 614 suppliers $12.00-$1590.00
2,2-Bis(hydroxymethyl)propionic acid 4767-03-7 C5H10O4 517 suppliers $6.00-$4084.08

Similar articles

IF:0.2

Pharmacokinetics of depot medroxyprogesterone acetate contraception.

生殖醫(yī)學(xué)雜志 D R Mishell,etc Published: 1 May 1996
IF:3.2

Dutasteride in Androgenetic Alopecia: An Update.

Current clinical pharmacology Tasleem Arif, Konchok Dorjay,etc Published: 1 January 2017
IF:2.8

Praziquantel treatment in trematode and cestode infections: an update.

Infection and Chemotherapy Jong-Yil Chai,etc Published: 1 March 2013
旬阳县| 嘉善县| 西充县| 仙桃市| 繁昌县| 新兴县| 城市| 临沭县| 揭东县| 随州市| 通河县| 孝义市| 玛沁县| 金川县| 太湖县| 稷山县| 西畴县| 桂东县| 乌兰察布市| 平舆县| 锦州市| 邛崃市| 本溪市| 临武县| 汉沽区| 娄底市| 高台县| 吉林省| 田阳县| 碌曲县| 铜山县| 铁岭市| 周宁县| 来宾市| 嘉义市| 桂平市| 龙游县| 上林县| 得荣县| 澄江县| 将乐县|